Your search returned 4 results.

Sort
Results
1.
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Hall J, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_7
2.
Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_2
3.
Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_7
4.
A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors:
  • Brennan, Michael T
  • Hall, Jordan
  • Khorjekar, Gauri
  • Van Nostrand, Douglas
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Hall J
  • Khorjekar G
  • McIver B
  • Van Nostrand D
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_050
Pages

Powered by Koha